2009年的《生物制品价格竞争与创新法案》(The Biologics Price Competition and Innovation Act ,BPCIA)在《公共卫生服务法案》(Public Health Service Act,PHS Act)第351(k)节中增加了生物类似药批准途径,同时基于该产品与先前根据PHS法案第351(a)条批准的参比制剂“生物类似(Biosimilar)”的证明,为生物制品建立了一...
We read every piece of feedback, and take your input very seriously. Include my email address so I can be contacted Cancel Submit feedback Saved searches Use saved searches to filter your results more quickly Cancel Create saved search Sign in Sign up Reseting focus {...
{integrity: sha512-ItUhSUxBBdNamkT3KzIZwYNNRFKmkJrofvC2nWab3CPKhYBQ1f27XXh1PAPE27Psx58jeelPsxWB/+og+KEH0Q==} - peerDependencies: - postcss: ^8.0.0 - dependencies: - generic-names: 4.0.0 - icss-replace-symbols: 1.1.0 - lodash.camelcase: 4.3.0 - postcss: 8.4.27 - postcss-modules...